Conformational Constraint between Aromatic Residue Side Chains in the “Message” Sequence of the Peptide Arodyn Using Ring Closing Metathesis Results in a Potent and Selective Kappa Opioid Receptor Antagonist | Journal of
Discovery of the First N-Substituted 4β-Methyl-5-(3-hydroxyphenyl)morphan To Possess Highly Potent and Selective Opioid δ Receptor Antagonist Activity | Journal of Medicinal Chemistry
Frontiers | Crosstalk Between Kappa Opioid and Dopamine Systems in Compulsive Behaviors
Kappa Opiate Receptor - an overview | ScienceDirect Topics
Discovery of Small Molecule Kappa Opioid Receptor Agonist and Antagonist Chemotypes through a HTS and Hit Refinement Strategy | ACS Chemical Neuroscience
Lion's Mane contains kappa agonist - Supplements - LONGECITY
Direct Selection of DNA-Encoded Libraries for Biased Agonists of GPCRs on Live Cells | JACS Au
A systematic review on the kappa opioid receptor and its ligands: New directions for the treatment of pain, anxiety, depression, and drug abuse - ScienceDirect
κ-opioid receptor - Wikipedia
Development of κ Opioid Receptor Antagonists | Journal of Medicinal Chemistry
Delta Opiate Receptor Antagonist - an overview | ScienceDirect Topics
Angiotensin‐converting enzymes as druggable features of psychiatric and neurodegenerative disorders - Santiago - Journal of Neurochemistry - Wiley Online Library
Nanobody-enabled monitoring of kappa opioid receptor states | Nature Communications
Structural Assessment of Agonist Efficacy in the μ-Opioid Receptor: Morphine and Fentanyl Elicit Different Activation Patterns | Journal of Chemical Information and Modeling
A Phase 3 Trial of Difelikefalin in Hemodialysis Patients with Pruritus | NEJM
Antagonists of the kappa opioid receptor - ScienceDirect
G protein-coupled receptor signaling: transducers and effectors | American Journal of Physiology-Cell Physiology
Nalfurafine, a G-Protein–Biased KOR (Kappa Opioid Receptor) Agonist, Enhances the Diuretic Response and Limits Electrolyte Losses to Standard-of-Care Diuretics | Hypertension
Pharmaceuticals | Free Full-Text | In Vitro, In Vivo and In Silico Characterization of a Novel Kappa-Opioid Receptor Antagonist
![Anti-HLA-DP antibody [B7/21] (ab20897) | Abcam](https://www.abcam.com/ps/products/20/ab20897/Images/ab20897-4-anti-hladp-b721-immunocytochemistry-antibody-ramos-human.jpg "Anti-HLA-DP antibody [B7/21] (ab20897) | Abcam")
Anti-HLA-DP antibody [B7/21] (ab20897) | Abcam
Molecules | Free Full-Text | Kappa Opioid Receptor Agonist Mesyl Sal B Attenuates Behavioral Sensitization to Cocaine with Fewer Aversive Side-Effects than Salvinorin A in Rodents
![Anti-HLA DR + DP + DQ antibody [CR3/43] (ab7856) | Abcam](https://www.abcam.com/ps/products/7/ab7856/Images/ab7856-448954-antihladrdpdqimmunohistochemistrytonsilhuman.jpg "Anti-HLA DR + DP + DQ antibody [CR3/43] (ab7856) | Abcam")
Anti-HLA DR + DP + DQ antibody [CR3/43] (ab7856) | Abcam
Kappa Opioid Receptor Activation Potentiates the Cocaine-Induced Increase in Evoked Dopamine Release Recorded In Vivo in the Mouse Nucleus Accumbens | Neuropsychopharmacology
